Cargando…
Cancer of unknown primary: Registered procedures compared with national integrated cancer pathway for illuminating external validity
Cancer of unknown primary (CUP) ranges within top 10 cancers in both incidence and mortality. As primary identification is crucial to choosing treatment, guidelines on CUP emphasize the diagnostic strategy. Whether guidelines are complied with, or if they are indeed helpful, is however unclear. We c...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406101/ https://www.ncbi.nlm.nih.gov/pubmed/28422885 http://dx.doi.org/10.1097/MD.0000000000006693 |
_version_ | 1783231905350549504 |
---|---|
author | Dyrvig, Anne-Kirstine Yderstræde, Knud Bonnet Gerke, Oke Jensen, Peter Bjødstrup Hess, Søren Høilund-Carlsen, Poul Flemming Green, Anders |
author_facet | Dyrvig, Anne-Kirstine Yderstræde, Knud Bonnet Gerke, Oke Jensen, Peter Bjødstrup Hess, Søren Høilund-Carlsen, Poul Flemming Green, Anders |
author_sort | Dyrvig, Anne-Kirstine |
collection | PubMed |
description | Cancer of unknown primary (CUP) ranges within top 10 cancers in both incidence and mortality. As primary identification is crucial to choosing treatment, guidelines on CUP emphasize the diagnostic strategy. Whether guidelines are complied with, or if they are indeed helpful, is however unclear. We compared procedures performed in suspected CUP patients with recommendations of national guidelines to assess external validity of guidelines. The Danish National Patient Registry (NPR) comprising population data was utilized to identify the suspected CUP patients during 2009 to 2010 and explore exposure to procedures and patient survival. The cohort was investigated in terms of validity of diagnosis through cross-referencing with the Cancer Registry (CR), which served as gold standard for cancer diagnoses and patients’ cancer histories. The NPR cohort consisted of 542 patients (275 males, 264 females) of whom 210 (38.7%) had a CUP diagnosis confirmed. Within the cohort, 347 patients (64.0%) had a registration in CR matching with the NPR registration. Exposure to diagnostic procedures included biopsy (n = 439, 81.0%) and image modalities (n = 532, 98.2%). Survival was poor with 67 (12.4%) individuals alive after 4 years. The validity of a CUP diagnosis in NPR was low when using data from CR as reference. More than half the suspected CUP patients had a previous cancer diagnosis with CUP being the most frequent. Patients were diagnosed in compliance with guidelines indicating high external validity, but less than 1 quarter had their primary identified and the 1-year survival was approximately 20%. Research is needed to develop efficacious methods for primary detection. |
format | Online Article Text |
id | pubmed-5406101 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-54061012017-04-28 Cancer of unknown primary: Registered procedures compared with national integrated cancer pathway for illuminating external validity Dyrvig, Anne-Kirstine Yderstræde, Knud Bonnet Gerke, Oke Jensen, Peter Bjødstrup Hess, Søren Høilund-Carlsen, Poul Flemming Green, Anders Medicine (Baltimore) 4400 Cancer of unknown primary (CUP) ranges within top 10 cancers in both incidence and mortality. As primary identification is crucial to choosing treatment, guidelines on CUP emphasize the diagnostic strategy. Whether guidelines are complied with, or if they are indeed helpful, is however unclear. We compared procedures performed in suspected CUP patients with recommendations of national guidelines to assess external validity of guidelines. The Danish National Patient Registry (NPR) comprising population data was utilized to identify the suspected CUP patients during 2009 to 2010 and explore exposure to procedures and patient survival. The cohort was investigated in terms of validity of diagnosis through cross-referencing with the Cancer Registry (CR), which served as gold standard for cancer diagnoses and patients’ cancer histories. The NPR cohort consisted of 542 patients (275 males, 264 females) of whom 210 (38.7%) had a CUP diagnosis confirmed. Within the cohort, 347 patients (64.0%) had a registration in CR matching with the NPR registration. Exposure to diagnostic procedures included biopsy (n = 439, 81.0%) and image modalities (n = 532, 98.2%). Survival was poor with 67 (12.4%) individuals alive after 4 years. The validity of a CUP diagnosis in NPR was low when using data from CR as reference. More than half the suspected CUP patients had a previous cancer diagnosis with CUP being the most frequent. Patients were diagnosed in compliance with guidelines indicating high external validity, but less than 1 quarter had their primary identified and the 1-year survival was approximately 20%. Research is needed to develop efficacious methods for primary detection. Wolters Kluwer Health 2017-04-21 /pmc/articles/PMC5406101/ /pubmed/28422885 http://dx.doi.org/10.1097/MD.0000000000006693 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 |
spellingShingle | 4400 Dyrvig, Anne-Kirstine Yderstræde, Knud Bonnet Gerke, Oke Jensen, Peter Bjødstrup Hess, Søren Høilund-Carlsen, Poul Flemming Green, Anders Cancer of unknown primary: Registered procedures compared with national integrated cancer pathway for illuminating external validity |
title | Cancer of unknown primary: Registered procedures compared with national integrated cancer pathway for illuminating external validity |
title_full | Cancer of unknown primary: Registered procedures compared with national integrated cancer pathway for illuminating external validity |
title_fullStr | Cancer of unknown primary: Registered procedures compared with national integrated cancer pathway for illuminating external validity |
title_full_unstemmed | Cancer of unknown primary: Registered procedures compared with national integrated cancer pathway for illuminating external validity |
title_short | Cancer of unknown primary: Registered procedures compared with national integrated cancer pathway for illuminating external validity |
title_sort | cancer of unknown primary: registered procedures compared with national integrated cancer pathway for illuminating external validity |
topic | 4400 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406101/ https://www.ncbi.nlm.nih.gov/pubmed/28422885 http://dx.doi.org/10.1097/MD.0000000000006693 |
work_keys_str_mv | AT dyrvigannekirstine cancerofunknownprimaryregisteredprocedurescomparedwithnationalintegratedcancerpathwayforilluminatingexternalvalidity AT yderstrædeknudbonnet cancerofunknownprimaryregisteredprocedurescomparedwithnationalintegratedcancerpathwayforilluminatingexternalvalidity AT gerkeoke cancerofunknownprimaryregisteredprocedurescomparedwithnationalintegratedcancerpathwayforilluminatingexternalvalidity AT jensenpeterbjødstrup cancerofunknownprimaryregisteredprocedurescomparedwithnationalintegratedcancerpathwayforilluminatingexternalvalidity AT hesssøren cancerofunknownprimaryregisteredprocedurescomparedwithnationalintegratedcancerpathwayforilluminatingexternalvalidity AT høilundcarlsenpoulflemming cancerofunknownprimaryregisteredprocedurescomparedwithnationalintegratedcancerpathwayforilluminatingexternalvalidity AT greenanders cancerofunknownprimaryregisteredprocedurescomparedwithnationalintegratedcancerpathwayforilluminatingexternalvalidity |